Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 83 peer-reviewed journal articles Updated
Neurology

Understanding Autosomal Dominant Complex Spastic Paraplegia

At a Glance

Autosomal Dominant Complex Spastic Paraplegia (AD-HSP) is a rare inherited disorder that causes progressive leg stiffness, weakness, and additional neurological symptoms like balance and memory issues. It occurs when genetic changes damage the spinal cord nerves carrying movement signals from the brain.

Receiving a diagnosis of Autosomal Dominant Complex Spastic Paraplegia can feel overwhelming. You are dealing with a condition that is rare and carries a complex name, which can lead to feelings of isolation [1][2]. It is normal to feel anxious when your doctor uses terms you have never heard before, or when you find that even some medical professionals are not deeply familiar with your specific condition [3]. This page is designed to help you understand the basics of your diagnosis so you can feel more confident when speaking with your care team.

What is Hereditary Spastic Paraplegia?

Hereditary Spastic Paraplegia (HSP) is not a single disease, but a large group of rare, inherited disorders [3][4]. The main feature of all types of HSP is a slow, progressive stiffness (spasticity) and weakness in the legs [5][3]. This happens because the long nerve fibers in your spine, called the corticospinal tracts, begin to wear down over time [5][6]. These nerves are like long electrical wires that carry “move” signals from your brain down to your legs; when they are damaged, the signals don’t get through correctly, causing the muscles to stay tight and weak [7][6].

Understanding “Autosomal Dominant”

The term autosomal dominant describes how the condition is passed down through families.

  • Autosomal: The gene involved is located on one of the numbered chromosomes that both men and women have.
  • Dominant: You only need to inherit one copy of the changed gene from one parent to have the condition [1].

If a person has an autosomal dominant form of HSP, there is a 50% (1 in 2) chance that they will pass the gene change to each of their children [1][8]. Sometimes, a person may be the first one in their family to have the condition because of a new gene change that happened for the first time in them (called a de novo mutation) [9][10].

“Pure” vs. “Complex” Forms

Doctors divide HSP into two main categories based on the symptoms a person experiences:

  1. Pure HSP: In these “uncomplicated” cases, the symptoms are mostly limited to the legs, including stiffness, weakness, and sometimes bladder urgency [5][3].
  2. Complex HSP: In “complicated” cases, the leg stiffness is joined by other neurological symptoms [5][3]. These “extra” symptoms can vary widely but may include:
    • Balance problems (ataxia) [11][12].
    • Changes in thinking or memory (cognitive impairment) [11][13].
    • Numbness or tingling in the hands and feet (peripheral neuropathy) [12].
    • Vision or hearing changes [11].
    • Specific changes in brain structure, such as a thinning of the corpus callosum (the bridge between the two sides of the brain), which can sometimes be seen on an MRI [14][15].

Why Your Local Doctor Might Not Know Much

Because HSP is a rare (orphan) disease, many general neurologists may only see one or two cases in their entire career [3]. The condition is also very heterogeneous, meaning it looks different in every person and can be caused by many different gene changes [16][17]. Because the symptoms—like leg stiffness—can look like other more common conditions (such as Multiple Sclerosis or ALS), it often takes a specialist in neurogenetics and advanced testing to provide the correct diagnosis [18][19][20].

Understanding that this is a rare, complex condition can help you realize why finding the right answers takes time. You are the most important member of your care team, and being informed is your best tool for managing your health [21].

Navigate this Guide:

01

The Genetics and Biology of AD-HSP

Learn the genetics and biology behind Autosomal Dominant Complex Spastic Paraplegia (AD-HSP). Understand SPG subtypes, inheritance patterns, and nerve damage.

02

The Diagnostic Journey: Genetics and Imaging

Learn how Complex Autosomal Dominant Hereditary Spastic Paraplegia (AD-HSP) is diagnosed. Understand genetic tests, MRI findings, and how it differs from ALS.

03

Building Your Care Team and Managing Symptoms

Learn to manage Autosomal Dominant Complex Spastic Paraplegia (AD-HSP) symptoms. Discover medications, physical therapy strategies, and care team building.

04

Prognosis and Living Well with AD-HSP

Learn about the prognosis and living well with Autosomal Dominant Hereditary Spastic Paraplegia (AD-HSP). Understand disease progression and symptom tracking.

Common questions in this guide

What is the difference between pure and complex Hereditary Spastic Paraplegia?
Pure HSP primarily causes progressive stiffness and weakness in the legs. Complex HSP includes these leg symptoms but also involves extra neurological issues, such as balance problems, memory changes, vision changes, or nerve numbness in the hands and feet.
What does autosomal dominant mean for my family?
Autosomal dominant inheritance means you only need one copy of the changed gene from one parent to develop the condition. If you have this gene, there is a 50 percent chance of passing it to each of your children.
Why is Hereditary Spastic Paraplegia difficult to diagnose?
HSP is a rare disease with symptoms, like leg stiffness, that often mimic more common conditions such as multiple sclerosis or ALS. An accurate diagnosis usually requires a specialist in neurogenetics and advanced genetic testing because the disease looks different in every person.
What other symptoms can happen with complex HSP besides leg weakness?
While symptoms vary, complex cases often include ataxia (balance problems), peripheral neuropathy (numbness or tingling), cognitive impairment, and changes to vision or hearing. Your neurologist will monitor these symptoms over time.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my condition 'pure' or 'complex,' and which specific symptoms led to that classification?
  2. 2.What is the specific gene mutation (the SPG type) identified in my genetic testing, if known?
  3. 3.How much experience does this clinic have in treating Hereditary Spastic Paraplegia specifically?
  4. 4.How will you monitor the 'complex' parts of my condition, such as my vision, balance, or memory, over time?
  5. 5.Can you recommend a physical or occupational therapist who has worked with patients with rare neurodegenerative disorders?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Association of an insertion mutation in PRRT2 with hereditary spastic paraplegia accompanied by polyneuropathy.

    Wang Z, Dong H, Ji X, et al.

    Journal of clinical laboratory analysis 2021; (35(6)):e23772 doi:10.1002/jcla.23772.

    PMID: 33826176
  2. 2

    Anaesthesia and orphan disease: Management of a case of Strumpell-Lorrain disease and review of the literature.

    Ponsonnard S, Damon A, Gueye EM

    European journal of anaesthesiology 2017; (34(8)):562-563 doi:10.1097/EJA.0000000000000615.

    PMID: 28682816
  3. 3

    Hereditary Spastic Paraplegia in Alberta: Lessons from a Well-Defined Cohort Including the Indigenous Population.

    Assaedi E, Ashtiani S, Estiar MA, et al.

    Movement disorders clinical practice 2025; (12(9)):1346-1356 doi:10.1002/mdc3.70115.

    PMID: 40322871
  4. 4

    Importance of lipids for upper motor neuron health and disease.

    Gunay A, Shin HH, Gozutok O, et al.

    Seminars in cell & developmental biology 2021; (112()):92-104 doi:10.1016/j.semcdb.2020.11.004.

    PMID: 33323321
  5. 5

    Hereditary spastic paraplegia caused by compound heterozygous mutations outside the motor domain of the KIF1A gene.

    Krenn M, Zulehner G, Hotzy C, et al.

    European journal of neurology 2017; (24(5)):741-747 doi:10.1111/ene.13279.

    PMID: 28332297
  6. 6

    Ascending Axonal Degeneration of the Corticospinal Tract in Pure Hereditary Spastic Paraplegia: A Cross-Sectional DTI Study.

    List J, Kohl Z, Winkler J, et al.

    Brain sciences 2019; (9(10)) doi:10.3390/brainsci9100268.

    PMID: 31601037
  7. 7

    Spinal cord structural changes in SPG4: insights from a large cohort using advanced neuroimaging.

    González-Salazar C, Pimentel-Silva LR, Rezende TJR, et al.

    Journal of neurology 2025; (272(9)):557 doi:10.1007/s00415-025-13251-5.

    PMID: 40762826
  8. 8

    A Nepalese family with an REEP2 mutation: clinical and genetic study.

    Nan H, Takaki R, Hata T, et al.

    Journal of human genetics 2021; (66(7)):749-752 doi:10.1038/s10038-020-00882-x.

    PMID: 33526816
  9. 9

    Clinical and Genetic Features of Chinese Patients With NIPA1-Related Hereditary Spastic Paraplegia Type 6.

    Fu J, Ma M, Li G, Zhang J

    Frontiers in genetics 2022; (13()):859688 doi:10.3389/fgene.2022.859688.

    PMID: 35464835
  10. 10

    A Patient with Calpainopathy Carrying Compound Heterozygous Mutations of a De Novo Pathogenic Variant of c.1333G>A and a Novel Variant of c.1331C>T in CAPN3.

    Komaki S, Kubota A, Katsuse K, et al.

    Internal medicine (Tokyo, Japan) 2024; (63(22)):3083-3086 doi:10.2169/internalmedicine.3435-23.

    PMID: 38494715
  11. 11

    Genetic and phenotypic characterization of complex hereditary spastic paraplegia.

    Kara E, Tucci A, Manzoni C, et al.

    Brain : a journal of neurology 2016; (139(Pt 7)):1904-18 doi:10.1093/brain/aww111.

    PMID: 27217339
  12. 12

    Identification of a novel mutation in ATP13A2 associated with a complicated form of hereditary spastic paraplegia.

    Odake Y, Koh K, Takiyama Y, et al.

    Neurology. Genetics 2020; (6(5)):e514 doi:10.1212/NXG.0000000000000514.

    PMID: 33134512
  13. 13

    Identification of a novel MAG gene mutation with 22q11.21 microduplication linked to hereditary spastic paraplegia.

    Kavishwar M, Bisen P, Baheti S, Wade P

    BMJ case reports 2024; (17(12)) doi:10.1136/bcr-2024-260342.

    PMID: 39689926
  14. 14

    "Ears of the Lynx" MRI Sign Is Associated with SPG11 and SPG15 Hereditary Spastic Paraplegia.

    Pascual B, de Bot ST, Daniels MR, et al.

    AJNR. American journal of neuroradiology 2019; (40(1)):199-203 doi:10.3174/ajnr.A5935.

    PMID: 30606727
  15. 15

    Hereditary spastic paraplegia: An "ears of the lynx" magnetic resonance imaging sign in a patient with recessive genetic type 11.

    Romagnoli ER, Akly MP, Miquelini LA, et al.

    The neuroradiology journal 2021; (34(1)):42-44 doi:10.1177/1971400920953820.

    PMID: 32885726
  16. 16

    Comprehensive Characterization of Spastic Paraplegia in Korean Patients: A Single-Center Experience over Two Decades.

    Choi Y, Kim SH, Ahn SJ, et al.

    Yonsei medical journal 2026; (67(1)):34-41 doi:10.3349/ymj.2024.0500.

    PMID: 41431411
  17. 17

    [Common forms of hereditary spastic paraplegias].

    Rudenskaya GE, Kadnikova VA, Ryzhkova OP

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2019; (119(2)):94-104 doi:10.17116/jnevro201911902194.

    PMID: 30874534
  18. 18

    SCA1 patients may present as hereditary spastic paraplegia and must be included in spastic-ataxias group.

    Pedroso JL, de Souza PV, Pinto WB, et al.

    Parkinsonism & related disorders 2015; (21(10)):1243-6.

    PMID: 26231471
  19. 19

    A novel KIF5A gene variant causes spastic paraplegia and cerebellar ataxia.

    Qiu Y, Zhong S, Cong L, et al.

    Annals of clinical and translational neurology 2018; (5(11)):1415-1420 doi:10.1002/acn3.650.

    PMID: 30480035
  20. 20

    Inherited metabolic diseases mimicking hereditary spastic paraplegia (HSP): a chance for treatment.

    Teive HAG, Camargo CHF, Pereira ER, et al.

    Neurogenetics 2022; (23(3)):167-177 doi:10.1007/s10048-022-00688-3.

    PMID: 35397036
  21. 21

    Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathways.

    Synofzik M, Schüle R

    Movement disorders : official journal of the Movement Disorder Society 2017; (32(3)):332-345 doi:10.1002/mds.26944.

    PMID: 28195350

This page provides educational information about Autosomal Dominant Complex Spastic Paraplegia. It does not replace professional medical advice or formal diagnostic testing from a qualified neurogeneticist or neurologist.

Get notified when new evidence is published on Autosomal dominant complex spastic paraplegia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.